0001209191-23-026734.txt : 20230502
0001209191-23-026734.hdr.sgml : 20230502
20230502185038
ACCESSION NUMBER: 0001209191-23-026734
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Bryan E.
CENTRAL INDEX KEY: 0001748041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 23881053
MAIL ADDRESS:
STREET 1: C/O UROVANT SCIENCES, INC.
STREET 2: 5281 CALIFORNIA AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Novus Therapeutics, Inc.
DATE OF NAME CHANGE: 20170511
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-01
0
0001404281
Eledon Pharmaceuticals, Inc.
ELDN
0001748041
Smith Bryan E.
C/O ELEDON PHARMACEUTICALS, INC.
19900 MACARTHUR BLVD STE. 550
IRVINE
CA
92612
0
1
0
0
General Counsel, Corporate Sec
0
Stock Option (right to buy)
2.30
2023-05-01
4
A
0
179000
0.00
A
2033-05-01
Common Stock
179000
179000
D
This option represents a right to purchase up to 179,000 shares of Common Stock, which option vests with respect to 44,750 shares on May 1, 2024, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending May 1, 2027.
/s/ Bryan Smith
2023-05-02